Nyxoah S A (NYXH)

$3.07 -0.26 (-7.81%)
Market Cap 129.07M
Revenue (ttm) 11.34M
Net Income (ttm) -101.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -898.77%
Debt to Equity Ratio 0.83
Volume 24,600
Avg Vol 44,222
Day's Range N/A - N/A
Shares Out 38.76M
Stochastic %K 43%
Beta 1.56
Analysts Strong Sell
Price Target $10.25

Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 32 1 045 90 75
Fax: 32 1 045 90 75
Address:
Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium
MarketBeat
MarketBeat May. 13 at 1:10 AM
https://marketbeat.com/a/8651187/ $NYXH Nyxoah Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 12 at 9:32 PM
https://www.marketbeat.com/earnings/reports/2026-5-12-nyxoah-sa-stock/ $NYXH Nyxoah Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 12 at 8:18 PM
$NYXH Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.37 up 38.33% YoY • Reported revenue of $6.37M up 498.87% YoY • Nyxoah expects Q2 2026 U.S. net revenue to grow 25-30% sequentially. Full year 2026 worldwide net revenue is projected between 36M and 40M, with gross margin between 60% and 62%.
0 · Reply
focafoca99
focafoca99 May. 12 at 8:12 PM
$NYXH announced its annual shareholders' meeting for June 10, 2026 and released its Q1 2026 results.
0 · Reply
anachartanalyst
anachartanalyst May. 12 at 1:01 PM
$NYXH https://anachart.com/wp-content/uploads/2026/05/1778590877_soc-img.jpg
0 · Reply
SuperGreenToday
SuperGreenToday May. 1 at 9:40 PM
$NYXH
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 29 at 3:14 PM
$NYXH Current Stock Price: $2.89
0 · Reply
bartwood
bartwood Apr. 14 at 9:59 AM
$NYXH
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 8 at 9:34 PM
$NYXH RSI: 49.19, MACD: -0.1878 Vol: 0.22, MA20: 3.17, MA50: 3.91 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
bartwood
bartwood Apr. 2 at 2:45 PM
$NYXH
0 · Reply
Latest News on NYXH
Nyxoah price target lowered to $7 from $9 at Piper Sandler

2026-05-13T11:14:11.000Z - 1 hour ago

Nyxoah price target lowered to $7 from $9 at Piper Sandler

Nyxoah reports Q1 EPS (EUR 0.37) vs. (EUR 0.60) last year

2026-05-12T22:33:58.000Z - 14 hours ago

Nyxoah reports Q1 EPS (EUR 0.37) vs. (EUR 0.60) last year

Nyxoah Reports First Quarter 2026 Financial and Operating Results

Tue, 12 May 2026 16:05:00 -0400 - 16 hours ago

Nyxoah Reports First Quarter 2026 Financial and Operating Results

Nyxoah downgraded to Hold from Buy at Stifel

2026-05-12T01:45:10.000Z - 1 day ago

Nyxoah downgraded to Hold from Buy at Stifel

INSP

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

Tue, 28 Apr 2026 16:05:00 -0400 - 14 days ago

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

Nyxoah price target lowered to $8 from $10 at Stifel

2026-04-10T11:45:49.000Z - 4 weeks ago

Nyxoah price target lowered to $8 from $10 at Stifel

Nyxoah price target lowered to $4.62 from $5.87 at Baird

2026-03-23T10:36:07.000Z - 7 weeks ago

Nyxoah price target lowered to $4.62 from $5.87 at Baird

Publication relating to transparency notifications

Fri, 20 Mar 2026 17:30:00 -0400 - 7 weeks ago

Publication relating to transparency notifications

Nyxoah price target lowered to $10 from $11 at Stifel

2026-03-20T11:45:13.000Z - 7 weeks ago

Nyxoah price target lowered to $10 from $11 at Stifel

Nyxoah Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 7 weeks ago

Nyxoah Earnings Call Transcript: Q4 2025

Nyxoah reports Q4 EPS (EUR 0.59) vs. (EUR 0.46) last year

2026-03-19T20:25:54.000Z - 7 weeks ago

Nyxoah reports Q4 EPS (EUR 0.59) vs. (EUR 0.46) last year

Nyxoah sees Q1 revenue up 25% vs. Q4

2026-03-19T20:25:46.000Z - 7 weeks ago

Nyxoah sees Q1 revenue up 25% vs. Q4

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Thu, 19 Mar 2026 16:10:00 -0400 - 7 weeks ago

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Nyxoah Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 16, 2026, 8:40 AM EDT - 2 months ago

Nyxoah Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Publication relating to transparency notification

Fri, 13 Mar 2026 17:30:00 -0400 - 2 months ago

Publication relating to transparency notification

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Wed, 11 Mar 2026 17:05:00 -0400 - 2 months ago

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Thu, 05 Mar 2026 16:05:00 -0500 - 2 months ago

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Information on the total number of voting rights and shares

Wed, 25 Feb 2026 16:30:00 -0500 - 2 months ago

Information on the total number of voting rights and shares

Nyxoah signs MoU with Sheikh Shakhbout Medical City

2026-02-18T21:30:45.000Z - 2 months ago

Nyxoah signs MoU with Sheikh Shakhbout Medical City

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

Feb 18, 2026, 4:05 PM EST - 2 months ago

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

Nyxoah price target lowered to $11 from $12 at Stifel

2026-01-29T13:35:17.000Z - 3 months ago

Nyxoah price target lowered to $11 from $12 at Stifel

Nyxoah to invest in manufacturing facility in Belgium

2026-01-21T21:30:45.000Z - 3 months ago

Nyxoah to invest in manufacturing facility in Belgium

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Jan 21, 2026, 4:05 PM EST - 3 months ago

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Nyxoah Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 15, 2026, 3:00 PM EST - 4 months ago

Nyxoah Transcript: 44th Annual J.P. Morgan Healthcare Conference

Nyxoah sees Q1 net revenue up 25% over Q1

2026-01-12T21:21:43.000Z - 4 months ago

Nyxoah sees Q1 net revenue up 25% over Q1

Nyxoah reports preliminary Q4 gross revenue EUR 6.3M

2026-01-12T21:15:31.000Z - 4 months ago

Nyxoah reports preliminary Q4 gross revenue EUR 6.3M

Publication relating to transparency notification

Jan 12, 2026, 1:00 AM EST - 4 months ago

Publication relating to transparency notification

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Dec 19, 2025, 4:05 PM EST - 5 months ago

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Nyxoah announces commercial launch of Genio system in the Netherlands

2025-12-17T10:15:09.000Z - 5 months ago

Nyxoah announces commercial launch of Genio system in the Netherlands

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Dec 17, 2025, 1:05 AM EST - 5 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Nyxoah price target lowered to EUR 5 from EUR 7 at Baird

2025-12-16T10:40:30.000Z - 5 months ago

Nyxoah price target lowered to EUR 5 from EUR 7 at Baird

Nyxoah Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 4, 2025, 1:30 PM EST - 5 months ago

Nyxoah Transcript: Piper Sandler 37th Annual Healthcare Conference

Publication relating to transparency notifications

Dec 2, 2025, 4:30 PM EST - 5 months ago

Publication relating to transparency notifications

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 27, 2025, 4:05 PM EST - 5 months ago

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nyxoah receives Medicare reimbursement increases for Genio

2025-11-26T10:35:21.000Z - 6 months ago

Nyxoah receives Medicare reimbursement increases for Genio

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Nov 26, 2025, 1:45 AM EST - 6 months ago

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Information on the total number of voting rights and shares

Nov 20, 2025, 4:30 PM EST - 6 months ago

Information on the total number of voting rights and shares

Nyxoah price target lowered to $9 from $12 at Piper Sandler

2025-11-14T11:45:23.000Z - 6 months ago

Nyxoah price target lowered to $9 from $12 at Piper Sandler

Nyxoah reports Q3 EPS (EUR 0.63) vs. (EUR 0.50) last year

2025-11-13T22:15:46.000Z - 6 months ago

Nyxoah reports Q3 EPS (EUR 0.63) vs. (EUR 0.50) last year

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nov 13, 2025, 4:36 PM EST - 6 months ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nyxoah Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 6 months ago

Nyxoah Earnings Call Transcript: Q3 2025

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nov 13, 2025, 4:12 PM EST - 6 months ago

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nyxoah Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 9:20 AM EST - 6 months ago

Nyxoah Transcript: Stifel 2025 Healthcare Conference

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Nov 3, 2025, 4:05 PM EST - 6 months ago

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Oct 30, 2025, 5:10 PM EDT - 6 months ago

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Nyxoah implants first U.S. commercial patients with Genio system

2025-10-06T09:20:27.000Z - 7 months ago

Nyxoah implants first U.S. commercial patients with Genio system

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Oct 6, 2025, 1:00 AM EDT - 7 months ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 23, 2025, 4:10 PM EDT - 8 months ago

Nyxoah Provides an Update on Expanded Middle East Presence

Nyxoah files patent infringement lawsuit against Inspire Medical

2025-09-15T20:15:33.000Z - 8 months ago

Nyxoah files patent infringement lawsuit against Inspire Medical

INSP

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 15, 2025, 4:10 PM EDT - 8 months ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Nyxoah Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 5:35 PM EDT - 8 months ago

Nyxoah Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Nyxoah Announces Upcoming Investor Events

Sep 2, 2025, 4:30 PM EDT - 9 months ago

Nyxoah Announces Upcoming Investor Events

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 18, 2025, 4:10 PM EDT - 9 months ago

Nyxoah Reports Second Quarter Financial and Operating Results

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 11, 2025, 1:00 AM EDT - 9 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Aug 8, 2025, 4:10 PM EDT - 9 months ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 29, 2025, 4:30 PM EDT - 10 months ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jul 28, 2025, 4:05 PM EDT - 10 months ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Jun 13, 2025, 1:00 AM EDT - 11 months ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 4:30 PM EDT - 1 year ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

Nyxoah Reports First Quarter Financial and Operating Results

May 14, 2025, 1:00 AM EDT - 1 year ago

Nyxoah Reports First Quarter Financial and Operating Results

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

May 9, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

Conditional Issuance of Shares

Apr 16, 2025, 2:00 AM EDT - 1 year ago

Conditional Issuance of Shares

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Apr 8, 2025, 1:00 AM EDT - 1 year ago

Nyxoah Provides Update on FDA Approvable Letter for Genio System

MarketBeat
MarketBeat May. 13 at 1:10 AM
https://marketbeat.com/a/8651187/ $NYXH Nyxoah Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 12 at 9:32 PM
https://www.marketbeat.com/earnings/reports/2026-5-12-nyxoah-sa-stock/ $NYXH Nyxoah Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 12 at 8:18 PM
$NYXH Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.37 up 38.33% YoY • Reported revenue of $6.37M up 498.87% YoY • Nyxoah expects Q2 2026 U.S. net revenue to grow 25-30% sequentially. Full year 2026 worldwide net revenue is projected between 36M and 40M, with gross margin between 60% and 62%.
0 · Reply
focafoca99
focafoca99 May. 12 at 8:12 PM
$NYXH announced its annual shareholders' meeting for June 10, 2026 and released its Q1 2026 results.
0 · Reply
anachartanalyst
anachartanalyst May. 12 at 1:01 PM
$NYXH https://anachart.com/wp-content/uploads/2026/05/1778590877_soc-img.jpg
0 · Reply
SuperGreenToday
SuperGreenToday May. 1 at 9:40 PM
$NYXH
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 29 at 3:14 PM
$NYXH Current Stock Price: $2.89
0 · Reply
bartwood
bartwood Apr. 14 at 9:59 AM
$NYXH
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 8 at 9:34 PM
$NYXH RSI: 49.19, MACD: -0.1878 Vol: 0.22, MA20: 3.17, MA50: 3.91 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
bartwood
bartwood Apr. 2 at 2:45 PM
$NYXH
0 · Reply
topstockalerts
topstockalerts Mar. 20 at 6:01 PM
$NYXH newer ticker behavior, still in discovery mode. Can get volatile as traders figure out range.
0 · Reply
Precision3ntries
Precision3ntries Mar. 20 at 4:35 PM
Watching: $DRMA $EDSA $NYXH $JAGU $WNW
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 19 at 9:18 PM
$NYXH Q4 '25 Earnings Results & Recap Nyxoah anticipates U.S. net revenue to grow approximately 25% sequentially in both Q1 2026 over Q4 2025, and Q2 2026 over Q1 2026, with international revenue following a typical seasonal pattern.
0 · Reply
bartwood
bartwood Mar. 16 at 1:53 PM
$NYXH
0 · Reply
mahesh_99
mahesh_99 Mar. 15 at 7:05 PM
$NYXH
0 · Reply
Lilingpeace
Lilingpeace Mar. 10 at 5:58 PM
$NYXH started initial positions here, hopefully Genio will take off
0 · Reply
Lilwopjob
Lilwopjob Mar. 3 at 8:47 PM
Is $NYXH going to eat $INSPS lunch? Position in neither but I’ve been researching / watching a couples months.
0 · Reply
notreload_ai
notreload_ai Feb. 26 at 7:46 PM
$INSP , $NYXH ... CMS resolves hypoglossal nerve stimulation reimbursement confusion by adding 6 new HCPCS codes (effective Jan 1, 2026), viewed as positive for Inspire & Nyxoah. https://notreload.xyz/cms-adds-hcpcs-codes-for-hgns-boost-for-inspire-nyxoah/
0 · Reply
InItToWinIt100
InItToWinIt100 Feb. 26 at 7:25 PM
$NYXH Out of nowhere! https://www.trade-ideas.com/share.php?code=Gr0mz3StGd380SJnyduBog5jhQsmkku0
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 21 at 6:00 PM
$NYXH RSI: 43.90, MACD: -0.0625 Vol: 0.14, MA20: 4.67, MA50: 4.77 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply